Which of the following is a common abnormal finding that may prompt further testing of a newborn?

Inconclusive metabolic screening

Inconclusive metabolic screening is a critical reason for further testing in newborns. Metabolic screenings are designed to detect certain genetic, metabolic, and endocrine disorders early in life, some of which can have serious health implications if not addressed promptly. An inconclusive result suggests that there may be underlying issues that need additional investigation to ensure the newborn's health and well-being. It is essential to identify these disorders early to allow for timely intervention and management, which can significantly improve outcomes for the infant.

Healthy weight and size, normal reflex responses, and passing hearing screening are all indicators of a newborn's well-being and suggest that the infant is developing appropriately. These findings do not warrant further testing, as they are generally considered normal and healthy outcomes in newborn assessments.

Healthy weight and size

Normal reflex responses

Passing hearing screening

Want more questions?

All options are one-time payments.

$25.99

30 day pass for new members

All the basics to get you started

  • Ad-free experience
  • View your previous attempt history
  • Mobile app access
  • In-depth explanations
  • 30 day premium pass access
$59.99 $171.99 usd

6 month DELUXE pass (most popular)

Everything with the 30 day premium pass FOR 6 MONTHS! & the ultimate digital PDF study guide (BONUS)

  • Everything included in the premium pass
  • $171.99 usd value for $59.99! You save $106!
  • + Access to the ultimate digital PDF study guide
  • + 6 months of premium pass access
  • + Priority support
$15.99 $24.99

Ultimate digital PDF study guide

For those that prefer a more traditional form of learning

  • Available for instant download
  • Available offline
  • Hundreds of practice multiple choice questions
  • Comprehensive content
  • Detailed explanations
Image Description
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy